CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- 4 Open-market buy CEO and CFO bought 2,200 shares at an average $13.43 ($29,555)
- 4 Open-market buy CEO and CFO bought 1,500 shares at $13.62 ($20,430)
- 4 Open-market buy CEO and CFO bought 3,600 shares at an average $13.06 ($47,018)
- 4 Open-market buy CEO and CFO bought 1,800 shares at $29.83 ($53,694)
- 4 Open-market buy CEO and CFO bought 2,900 shares at $27.54 ($79,866)
- 4 Open-market buy CEO and CFO bought 4,300 shares at $21.36 ($91,848)
- 4 Open-market buy CEO and CFO bought 2,900 shares at $21.73 ($63,017)
- 4 Open-market buy CEO and CFO bought 4,100 shares at $12.62 ($51,742)
- 4 Open-market buy CEO and CFO bought 4,600 shares at $8.37 ($38,502)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and CFO bought 10,600 shares at $8.43 ($89,358)
- 4 Open-market buy CEO and CFO bought 2,300 shares at $9.26 ($21,298)
- 4 Open-market buy CEO and CFO bought 3,600 shares at $9.88 ($35,568)
- 4 Open-market buy CEO and CFO bought 5,400 shares at $8.98 ($48,492)
- 4 Open-market buy CEO and CFO bought 3,600 shares at $9.10 ($32,760)
- 4 Open-market buy CEO and CFO bought 5,500 shares at $8.73 ($48,015)
- 4 Open-market buy CEO and CFO bought 2,500 shares at $12.51 ($31,275)
- 4 Open-market buy CEO and CFO bought 2,900 shares at an average $13.58 ($39,391)
- 4 Open-market buy CEO and CFO bought 3,400 shares at $12.95 ($44,030)
- 4 Open-market buy CEO and CFO bought 2,000 shares at $11.97 ($23,940)
Page 1 of 8 · 146 filings